REG-Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 104,022 of its own shares between June 29 and July 3, 2026, continuing the buyback program announced earlier in June. The transactions were executed across multiple trading venues at an average price of €26.24 per share, resulting in a total expenditure of approximately €2.73 million.
Key figures
- Average price eur
- 26.24
- Shares held total
- 303756
- Shares repurchased
- 104022
- Repurchase cost eur
- 2,730,010.70
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.